Bio‑Diagnostics has recently expanded its respiratory diagnostics portfolio to support clinicians in identifying and managing respiratory conditions. The high‑quality respiratory diagnostics we offer are designed to deliver reliable, timely results, helping healthcare professionals make confident decisions and improve patient care at every stage of the respiratory pathway.
Respiratory Diagnosis and Management
FeNO: Efficient Biomarker for Asthma Management
Fractional exhaled Nitric Oxide (FeNO) is the internationally standardised, non-invasive biomarker for airway inflammation. Its pivotal role in asthma management is recognised by leading clinical bodies like NICE, BTS, and SIGN. The UK‘s asthma guideline (NG245) recommends FeNO testing for both diagnosis and therapy monitoring. FeNO is preferred over other objective tests as it minimizes effort, cost, and patient burden, while demonstrating high reliability. In patients with a history suggesting asthma, a single positive FeNO test (adults ≥ 50ppb | children ≥ 35ppb) is sufficient for diagnosis.
Vivatmo System by Bosch: The Smartest Choice for FeNO Testing
Bosch’s Vivatmo System combines the accuracy of German engineering with a smart, user-centric design. Available for both clinical and home use, it is officially distributed in the UK by Bio-Diagnostics.
Vivatmo pro:
The FeNO device for professional use delivers guideline-compliant FeNO values in seconds
Reliability: Powered by a 100% maintenance-free Bosch sensor, it requires no recalibration or servicing for the entire product life.
Joy of Use: Its smart design simplifies daily workflows and ensures the shortest total test time¹.
Time & Cost Saving: Integrates seamlessly with IT systems and offers transparent pricing without hidden costs.
¹Idzko et al. 2025; DOI: 10.1038/s41598-025-92664-8
Vivatmo me:
Empowers patients with the world‘s first FeNO device for home use, including optional asthma diary app
Clinical Insights: Continuous inflammation profiles and apprecorded context data enable a more precise diagnosis, earlier risk detection and targeted therapy
Reliability: 100% maintenance-free sensor technology for readings doctors and patients can trust.
Joy of Use: Its intuitive design and smart app support simplify home monitoring and encourage patient adherence.
BOSCH Vivatmo – Video
With Vivatmo, Bosch Healthcare Solutions is now bringing a recognised exhaled breath measurement system out of the clinician’s office straight into patients’ homes. The Vivatmo systems support treatment decision-making and progress monitoring. Experience these BOSCH products and services that are “Invented for life”.
At-home FeNO
monitoring
A new dimension to asthma management with the Vivatmo me paired with the free-to-download Vivatmo app. The Vivatmo app features a FeNO diary, a pollen diary and a new visualisation feature, making this at-home device as seamless to use as the Vivatmo pro.
Downloads (PDF)
Asthma management informed by NICE guidelines
NICE asthma guidelines place FeNO testing at the centre of modern airway inflammation assessment, supporting more accurate diagnosis and ongoing treatment optimisation. Incorporating FeNO into routine practice helps identify type 2 inflammation earlier, tailor inhaled corticosteroid therapy and reduce exacerbation risk. BOSCH Vivatmo FeNO systems provide a practical way to implement these recommendations in both clinic and home‑monitoring pathways, supporting data‑driven, personalised asthma management.
For Patients
What is Lung Inflammation?
An allergy is when your body reacts to something that is usually harmless, such as pollen, food, or animal fur. Your immune system sees this trigger as a threat and responds by causing symptoms like sneezing, a runny nose, itchy skin, or breathing problems.
Allergies can range from mild to serious. Even if your symptoms seem small, it’s important not to ignore them. Getting the right diagnosis helps you understand what is causing your symptoms and how best to manage them.
What is FeNO and how can it help me?
FeNO (fractional exhaled nitric oxide) is a simple breath test that shows the level of inflammation in your lungs. It can be measured in clinic or, with the right device, monitored at home. Regular FeNO measurements help you and your healthcare team see how well your medication is working sooner, so treatment can be adjusted more quickly. This can lower the risk of severe symptoms and help prevent serious flare‑ups, such as asthma attacks.
NICE Guidelines
NICE (the National Institute for Health and Care Excellence) provides evidence‑based guidelines to help doctors and nurses choose the best tests and treatments. In recent years, FeNO testing has become an important part of these guidelines for asthma. NICE recommends FeNO to help confirm a diagnosis and to monitor airway inflammation over time, so treatment can be better tailored and the risk of flare‑ups reduced.
